Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?

Publication
Article
BioPharm InternationalBioPharm International-03-15-2002
Volume 15
Issue 3

by Jill Wechsler, pp. 55-57, 60 The industry must ensure that manufacturing systems can produce high quality and consistent therapies, efforts that may lead to comparable "subsequent entry" products.

Recent Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.